12:00 AM
 | 
May 10, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Pleconaril: Phase III

University of California School of Medicine (San Diego) researchers presented final data from a study of 221 children ages 4-14 showing 50, 38 and 46 percent reductions in headache, disease symptoms or global assessment score...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >